-
France farmer protests: 100 tractors in Paris, roadblocks remain elsewhere
Farmers continue to blockade a number of routes ahead of Mercosur vote on Friday
-
Red weather alert issued as Storm Goretti brings 140km/h winds to northern France
Trains in Normandy and Brittany cancelled and ferry services disrupted
-
Strikes and protests in January 2026 and how you may be affected
Doctors, rail staff, and farmers are all taking action
Medical cannabis tests to start in January in France
First tests of medicinal cannabis should start early next year for 3,000 patients with illnesses such as epilepsy, neuropathic pain, multiple sclerosis and chemotherapy side-effects, plus those on palliative care.
The Agence Nationale de Sécurité du Médicament (ANSM) delayed work on the two-year study until January to set up a national electronic patient monitoring and support network and select suppliers. Patients will use cannabis in the form of oil taken orally or dried flowers by inhalation, but smoking will not be allowed due to its ill effects.
Medical cannabis: how will it work?
Cannabis will only be prescribed “as a last resort” after other treatments have failed and there will be no cost for patients taking part in the trial. Hospitals across the country are taking part, with patients put forward by a specialist, neurologist or pain control doctor.
Advertisment
The ANSM says the trial is not aimed at deciding the effectiveness of medical cannabis, as this is already known, but rather to gauge supply and follow-up. Terminology has changed from “therapeutic cannabis”, which implied general beneficial effects, to “medical cannabis”, for specific health benefit.
